Loading menu...
Prostate cancer is the second leading cause of cancer deaths among US men  Over 200,000 new patients are diagnosed with prostate cancer every year in the US alone  About 35,000 of these men have advanced metatstatic prostate tumor for whom there is no cure 

Investments

 

Colby has accessed and is accessing data from about $15M public and private grant funded studies including SBIR and two RAPID awards from National Institute of Health, USA for Colby drug discovery and development for clinical trial for the treatment of prostate cancer.